Abbott Laboratories (ABT) Raw Materials (2009 - 2026)

Abbott Laboratories has disclosed Raw Materials across 18 years of filings, most recently posting $1.7 billion for Q1 2026.

• Raw Materials for Q1 2026 came in at $1.7 billion, up 2.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 2.08% YoY), and the FY2025 annual result was $1.6 billion, down 2.78% from the prior year.
• Raw Materials came in at $1.7 billion for Q1 2026 at Abbott Laboratories, up from $1.6 billion in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.0 billion in Q2 2023 to a low of $1.5 billion in Q1 2022.
• The 5-year median for Raw Materials is $1.7 billion (2022), against an average of $1.7 billion.
• Across the five-year window, Raw Materials increased 26.08% in 2023 and declined 10.73% in 2025, its largest moves.
• Abbott Laboratories' Raw Materials stood at $1.7 billion in 2022, then climbed by 7.64% to $1.8 billion in 2023, then slipped by 8.97% to $1.7 billion in 2024, then dropped by 2.78% to $1.6 billion in 2025, then increased by 7.03% to $1.7 billion in 2026.
• The last three Raw Materials figures came in at $1.7 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.